Clicky

Propanc Biopharma Inc.(PPCB)

Description: Propanc Biopharma, Inc., a development-stage healthcare company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. The company's lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. Propanc Biopharma, Inc. has a research collaboration with University of JaƩn to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was founded in 2007 and is based in Camberwell, Australia.


Keywords: Biotechnology Cancer Life Sciences Drug Discovery Cancer Treatment E Health Colorectal Cancer Enzymes Pancreatic Sarepta Therapeutics

Home Page: www.propanc.com

302, 6 Butler Street
Camberwell, VIC 3124
Australia
Phone: 61 3 9882 0780


Officers

Name Title
Mr. James Nathanielsz Exec. Chairman, CEO, CFO, Treasurer & Sec.
Dr. Julian Norman Kenyon ChB, M.D., MB Chief Scientific Officer, CTO & Director
Prof. Klaus Kutz Chief Medical Officer & Member of Scientific Advisory Board

Exchange: OTCQB

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 0
IPO Date:
Fiscal Year End: June
Full Time Employees: 1
Back to stocks